News
Opinion
Opinion: Understanding What Trump’s MFN Executive Order Can and Can’t Do
The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, administrative friction and unintended consequences for both the healthcare sector and patient access.
Trump’s Executive Order on Drug Prices, Explained
More than 100 days into President Donald Trump’s second term, the administration has fallen into a pattern. Trump releases an executive order with an expansive title accompanied by even more expansive claims from the president and senior officials about the effects of the directive.
The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first ...
President Donald Trump announced Sunday that he plans to resurrect a controversial policy from his first term that aims to ...
AARP also calls on Congress to protect and strengthen Medicare’s ability to negotiate lower drug prices for millions of older ...
The new executive order builds on that policy by not limiting it to certain drugs under Medicare but also including Medicaid and private sector insurance available on the commercial marker ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback